Skip to content

Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)

Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01655368
Acronym
STEM
Enrollment
486
Registered
2012-08-01
Start date
2012-05-31
Completion date
2015-06-30
Last updated
2016-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Schizophrenia

Brief summary

This multi-center, 2-arm interventional study within different mental health care settings (psychiatry: in-patient, day-unit and out-patient, as well as psychiatric rehabilitation) evaluates a psychotherapeutic group intervention to improve stigma coping and empowerment using a psychotherapeutic module embedded in a psychoeducational group therapy.

Detailed description

People with mental illness suffer both from the burden of disease itself and from the social stigma related to mental illness, hence impeding their treatment (Sartorius et al. 2005, Link et al. 1999). Negative attitudes towards and discriminating behavior against people with mental illness negatively affect health care utilization, the course of disease, compliance, self-esteem, and social functioning (Sirey et al. 2001, Link et al. 2001, Perlick et al. 2001). Internalizing negative social stereotypes (self-stigmatization; Ritsher et al. 2003, Watson et al. 2007) impairs the quality of life and leads to social withdrawal (Rüesch 2005). Furthermore, self stigma is associated with lower empowerment (Ritsher et al. 2004), a poorer social network (Lysaker et al. 2007), lower compliance (Fung et al. 2008) and a higher extent of symptoms (Corrigan et al. 2006). The stigma of mental illness leads to an impaired pursuance of individual life goals, as job-related ambitions or living in a relationship (Rüesch 2005). Current approaches targeting the stigma of mental illness primarily focus on education about mental illness in different target groups (e.g. Gaebel et al. 2003, 2004) and can be successful, if appropriately implemented (Gaebel et al. 2008). Yet there is a lack of RCT-tested psychotherapeutic approaches which directly address patients with mental illness improving their skills of coping with stigma and discrimination. Therefore it is intended to develop, manualise, and to evaluate such a psychotherapeutic group intervention within a randomized clinical control group design. In this context, group-based cognitive-behavioral psychotherapy has been proved as efficient therapeutic approach for patients with depression (cf. McDermut et al. 2006) and with schizophrenia (cf. Lawrence et al. 2006, Barrowclough et al. 2006) in different settings. Patients can serve each other as role models and will modify negative self-related cognitions, thus developing new cognitions supporting self-esteem (Corrigan et al. 2001). The following interventional effects should improve the patients' quality of life and also result in a reduction of frequency and length of inpatient stays and sickness-related absenteeism: * improved skills to cope with negative stigmatizing experiences, * a reduced burden through of self-stigmatizing cognitions, * a better utilization of resources for disease managing in coherence with reduced self-stigmatization, and * an improved coping with stigma-related conflicts at work.

Interventions

BEHAVIORALpsychotherapeutic STEM modules

psychoeducational and psychotherapeutical group intervention. 8 sessions of psychoeducation + 3 sessions + 1 booster session of STEM module for schizophrenia or depression)

BEHAVIORALInterventional control of normal psychoeducational treatment

11 sessions + 1 booster session of psychoeducation (for schizophrenia or depression)

Sponsors

German Federal Ministry of Education and Research
CollaboratorOTHER_GOV
Wolfgang Gaebel, Professor
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 - 65 years * ICD-10 diagnosis of F2, F31.3-31.5, F32-34, F34.2, F43.2 * patients who would participate in a psychoeducational group therapy in their regular treatment * written informed consent of the patient willing to participate * capacity of giving consent (as diagnosed by the investigator)

Exclusion criteria

* insufficient knowledge of german language (reading, understanding and speaking not sufficient, as judged by the investigator) * acute psychotic or dissociative condition

Design outcomes

Primary

MeasureTime frameDescription
subjective quality of life12 months after interventionsubjective quality of life 12 months after intervention determined by WHOQOL-BREF total score. To impart coping-strategies in handling stigmatization and to develop empowerment by embedding a psychotherapeutic module in psychoeducational groups.

Secondary

MeasureTime frame
self-stigma (ISMI)after 6 weeks, 6 months, 12 months
empowerment (BUES)after 6 weeks, 6 months, 12 months
health care utilization (CSSRI, EQ5-D, SF-36)after 6 weeks, 6 months, 12 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026